Submit Manuscript    >>    Login | Register


Atrial fibrillation (AF) is a frequently encountered rhythm disorder, characterized by high recurrence rate, frequent hospitalizations, reduced quality-of-life and increased the risk of mortality, heart failure and stroke.  Along with these clinical complications this type of arrhythmia is the major driver of health-related expenditures. Radiofrequency catheter ablation (RFA) of atrial fibrillation has been shown to improve freedom from arrhythmia survival, reduce re-hospitalization rate and provide better quality-of-life as compared with rate control and rhythm control with antiarrhythmic therapy.  Efficacy of AF ablation in terms of outcomes and costs has an evolving importance. In this review, we thought to highlight current knowledge on cost-effectiveness of AF ablation.

Credits: Gulmira Kudaiberdieva, MD, FESC; Bulent Gorenek, MD, FESC, FACC

Biosense Webster
event date
Introduction to AFib
Ablation Specialist

View Ablation Specialists